DHR vs MRKR · P/E 39, rev $6.26B vs rev $751.7K
Danaher Corporation (DHR) versus Marker Therapeutics Inc (MRKR) — a side-by-side from cached financials, not a winner call.
Danaher Corporation (DHR) is a diagnostics & research company listed on US.
Marker Therapeutics Inc (MRKR) is a biotechnology company listed on US.
Latest reported DHR revenue for 2026-06-26 was $6.26B. Net income was $870.0M. Revenue was up 5.3% from 2026-03-27 to 2026-06-26. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
Latest reported MRKR revenue for 2026-03-31 was $751.7K. Net income was -$3.2M. Revenue was down 69.2% from 2025-09-30 to 2026-03-31. MRKR currently screens at market cap $25.3M.
DHR currently screens at market cap $144.18B and trailing P/E 39.0. MRKR currently screens at market cap $25.3M.
Not investment advice. Open the DHR and MRKR stock pages for the full models.
Not investment advice.